bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Figures 1-10 from Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation
Authors: Teijeira Alvaro , Labiano Sara , Garasa Saray , Etxeberria Iñaki , Santamaría Eva , Rouzaut Ana , Enamorado Michel , Azpilikueta Arantza , Inoges Susana , Bolaños Elixabet , Aznar Maria Angela , Sánchez-Paulete Alfonso R. , Sancho David , Melero Ignacio
Published: April 2023

Figure S1 shows that CD8 T cells with high mitochondrial transmembrane potential after CD137 stimulation have enlarged mitochondria. Fig S2 shows that CD137 induced mitochondrial changes are not due to enrichment of specific CD8 T cells subsets. Figure S3 shows that mitochondrial enhanced functions induced by CD137 activation are not a consequence of autocrine secretion of cytokines. Fig S4 shows that spare respiratory capacity induced by CD137 activation is dependent on fatty acid oxidation. Figure S5 explores regulation of mitochondrial biogenesis and fusion related genes upon CD137 activation. Fig S6 shows functional effects of OPA knockdown in CD8 T cells. Figure S7 shows the implication of Akt pathway on enhanced mitochondrial function by CD137 activation. Figure S8 shows that CD137KO CD8 T cells have intrinsic mitochondrial defects upon CD28 activation. Figure S9 shows that CD137 activation enhances mitochondrial parameters in tumor infiltrating lymphocytes. Fig S10 shows engrafment abilities and memory markers of OTI cells in B16OVA tumor bearing mice upon OPA silencing and CD137 mAb treatment.
Figure S5 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors
Authors: Francica Brian J. , Ghasemzadeh Ali , Desbien Anthony L. , Theodros Debebe , Sivick Kelsey E. , Reiner Gabrielle L. , Hix Glickman Laura , Marciscano Ariel E. , Sharabi Andrew B. , Leong Meredith L. , McWhirter Sarah M. , Dubensky Thomas W. , Pardoll Drew M. , Drake Charles G.
Published: April 2023

S5: Outgrowth and CDN treatment of B16F10 is effected in selected knockout animals.
Figure S1 from TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors
Authors: Francica Brian J. , Ghasemzadeh Ali , Desbien Anthony L. , Theodros Debebe , Sivick Kelsey E. , Reiner Gabrielle L. , Hix Glickman Laura , Marciscano Ariel E. , Sharabi Andrew B. , Leong Meredith L. , McWhirter Sarah M. , Dubensky Thomas W. , Pardoll Drew M. , Drake Charles G.
Published: April 2023

S1: Timeline of necrosis after CDN injection.
Table S3 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
Authors: Nath Pulak Ranjan , Pal-Nath Dipasmita , Mandal Ajeet , Cam Margaret C. , Schwartz Anthony L. , Roberts David D.
Published: April 2023

Supplemental Table 3. Gene list of DEG normalized and log2 transformed expression values of significantly differentially expressed genes within the following contrasts: Cd47-/- Uninfected vs WT Uninfected, WT Tumor bearing vs WT Uninfected, Cd47-/- Tumor bearing vs Cd47-/- Uninfected and Cd47-/- Tumor bearing vs WT Tumor bearing.
Supplementary Tables from A Multikinase and DNA-PK Inhibitor Combination Immunomodulates Melanomas, Suppresses Tumor Progression, and Enhances Immunotherapies
Authors: Tsai Alexander K. , Khan Asra Y. , Worgo Christina E. , Wang Lucy L. , Liang Yuanyuan , Davila Eduardo
Published: April 2023

Table S1: Human melanoma cell lines and mutation status Table S2: Differences in PD-L1 and CD155 drug responses between BRAF- and NRAS-mutant cell lines Table S3: Differences in HLA-I and CD73 drug responses between BRAF- and NRAS-mutant cell lines Table S4: Differences in NGFR and CD55 drug responses between BRAF- and NRAS-mutant cell lines Table S5: Differences in PD-L1, CD155, and HLA-I drug responses in BRAF-mutant cell lines Table S6: Differences in CD73, NGFR, and CD55 drug responses in BRAF- mutant cell lines Table S7: Differences in PD-L1, CD155, and HLA-I drug responses in NRAS- mutant cell lines Table S8: Differences in CD73, NGFR, and CD55 drug responses in NRAS- mutant cell lines Table S9: Fractional product analysis of Reg, anti-CD40, and STING agonist in vivo results Table S10: Fractional product analysis of Reg and adoptive cell transfer in vivo results
Supplementary Figure S4 from Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
Authors: Dougan Michael , Ingram Jessica R. , Jeong Hee-Jin , Mosaheb Munir M. , Bruck Patrick T. , Ali Lestat , Pishesha Novalia , Blomberg Olga , Tyler Paul M. , Servos Mariah M. , Rashidian Mohammad , Nguyen Quang-De , von Andrian Ulrich H. , Ploegh Hidde L. , Dougan Stephanie K.
Published: April 2023

S4. Lack of efficacy of B3-IL2 in KPC model and A12-GMCSF in Panc02 model.
Supplemental Figures 1-10, Supplemental Tables 1 and 2 from Mast Cell–Dependent CD8+ T-cell Recruitment Mediates Immune Surveillance of Intestinal Tumors in ApcMin/+ Mice
Authors: Bodduluri Sobha R. , Mathis Steven , Maturu Paramahamsa , Krishnan Elangovan , Satpathy Shuchismita R. , Chilton Paula M. , Mitchell Thomas C. , Lira Sergio , Locati Massimo , Mantovani Alberto , Jala Venkatakrishna R. , Haribabu Bodduluri
Published: April 2023

S1: Unaltered tumor burden in colons of ACKR2-/-ApcMin/+ mice. S2: Delayed onset of tumor development in the small intestine of ACKR2-/-ApcMin/+ mice. S3. Decreased inflammatory markers in the distal intestine tumors of ACKR2-/-ApcMin/+ mice. S4. Elevated mast cell infiltration into microadenomas in ACKR2-/-ApcMin/+ mice. S5. Identification of BMMC. S6. Relative expression levels of chemokine receptors in BMMC. S7. Dinitrophenyl (DNP) induced calcium release in BMMC. S8. Analysis of CCR2 and CCR5 expression in immune cells from ACKR2-/- mice. S9. Uptake and MHC-1 mediated presentation of peptide antigens by mast cells. S10. Mast cell infiltration into ACKR2-/- tumors is not dependent on T cells. Supplemental Table 1: List of primers used for mouse genotyping. Supplemental Table 2: List of mouse Real Time PCR primer sequences.
Figure S1 from Nanobody–Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses
Authors: Woodham Andrew W. , Cheloha Ross W. , Ling Jingjing , Rashidian Mohammad , Kolifrath Stephen C. , Mesyngier Maia , Duarte Joao N. , Bader Justin M. , Skeate Joseph G. , Da Silva Diane M. , Kast W. Martin , Ploegh Hidde L.
Published: April 2023

Supplemental Figure 1
Supplementary Table 2 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
Authors: Frazao Alexandra , Messaoudene Meriem , Nunez Nicolas , Dulphy Nicolas , Roussin France , Sedlik Christine , Zitvogel Laurence , Piaggio Eliane , Toubert Antoine , Caignard Anne
Published: April 2023

Supplementary Table 2
Supplementary Figure 1 from CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer–Draining Lymph Nodes
Authors: Frazao Alexandra , Messaoudene Meriem , Nunez Nicolas , Dulphy Nicolas , Roussin France , Sedlik Christine , Zitvogel Laurence , Piaggio Eliane , Toubert Antoine , Caignard Anne
Published: April 2023

Supplementary Figure 1
Supplementary Figure 2 from NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Authors: Guillamón Concepción F. , Martínez-Sánchez María V. , Gimeno Lourdes , Mrowiec Anna , Martínez-García Jerónimo , Server-Pastor Gerardo , Martínez-Escribano Jorge , Torroba Amparo , Ferri Belén , Abellán Daniel , Campillo José A. , Legaz Isabel , López-Álvarez María R. , Moya-Quiles María Rosa , Muro Manuel , Minguela Alfredo
Published: April 2023

Supplementary Figure 2
Supplementary Figure 1 from NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Authors: Guillamón Concepción F. , Martínez-Sánchez María V. , Gimeno Lourdes , Mrowiec Anna , Martínez-García Jerónimo , Server-Pastor Gerardo , Martínez-Escribano Jorge , Torroba Amparo , Ferri Belén , Abellán Daniel , Campillo José A. , Legaz Isabel , López-Álvarez María R. , Moya-Quiles María Rosa , Muro Manuel , Minguela Alfredo
Published: April 2023

Supplementary Figure 1
Supplemental Table 1 from Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist
Authors: Polesso Fanny , Weinberg Andrew D. , Moran Amy E.
Published: April 2023

TCRseq Deposits
Table S1 from Endoplasmic Reticulum Stress Contributes to Mitochondrial Exhaustion of CD8+ T Cells
Authors: Hurst Katie E. , Lawrence Kiley A. , Essman Matthew T. , Walton Zeke J. , Leddy Lee R. , Thaxton Jessica E.
Published: April 2023

FACS antibodies
Supplementary Tables from Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia
Authors: Banerjee Priyanka , Zhang Ronghua , Ivan Cristina , Galletti Giovanni , Clise-Dwyer Karen , Barbaglio Federica , Scarfò Lydia , Aracil Miguel , Klein Christian , Wierda William , Plunkett William , Caligaris-Cappio Federico , Gandhi Varsha , Keating Michael J. , Bertilaccio Maria Teresa S.
Published: April 2023

Supplementary Tables S1-S12
Supplementary Figures and Legends from Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma
Authors: Nejo Takahide , Matsushita Hirokazu , Karasaki Takahiro , Nomura Masashi , Saito Kuniaki , Tanaka Shota , Takayanagi Shunsaku , Hana Taijun , Takahashi Satoshi , Kitagawa Yosuke , Koike Tsukasa , Kobayashi Yukari , Nagae Genta , Yamamoto Shogo , Ueda Hiroki , Tatsuno Kenji , Narita Yoshitaka , Nagane Motoo , Ueki Keisuke , Nishikawa Ryo , Aburatani Hiroyuki , Mukasa Akitake , Saito Nobuhito , Kakimi Kazuhiro
Published: April 2023

Supplementary Table Legends and Information, Supplementary Figures 1-11
Supplementary Data from NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
Authors: Parihar Robin , Rivas Charlotte , Huynh Mai , Omer Bilal , Lapteva Natalia , Metelitsa Leonid S. , Gottschalk Stephen M. , Rooney Cliona M.
Published: April 2023

Fig. S1 shows characterization of GD2-specific CAR-T cells. Fig. S2 shows characterization of human MDSCs. Fig. S3 shows characterization of TME xenograft model. Fig. S4 shows GD2.CAR-T cell homing and infiltration into MDSC-containing tumors after NK cell infusion. Fig. S5 shows infiltration of NK cell and GD2.CAR-T cells by IHC.
Figures S1-S10 from Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity
Authors: Murter Benjamin , Pan Xiaoyu , Ophir Eran , Alteber Zoya , Azulay Meir , Sen Rupashree , Levy Ofer , Dassa Liat , Vaknin Ilan , Fridman-Kfir Tal , Salomon Ran , Ravet Achinoam , Tam Ada , Levin Doron , Vaknin Yakir , Tatirovsky Evgeny , Machlenkin Arthur , Pardoll Drew , Ganguly Sudipto
Published: April 2023

Supplementary Figures and Figure Legends
Figure S3 from The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer
Authors: Spinner Camille A. , Lamsoul Isabelle , Métais Arnaud , Febrissy Chanaëlle , Moog-Lutz Christel , Lutz Pierre G.
Published: April 2023

Figure S3 shows the numbers of IL-17A+ or FoxP3+IL-10+ in CD4+ cells in the spleen, mesenteric lymph nodes and colon of untreated control and cKO mice.
Supplementary Figure 8 from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Figure 8
Video 1 from Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors
Authors: Nagaya Tadanobu , Friedman Jay , Maruoka Yasuhiro , Ogata Fusa , Okuyama Shuhei , Clavijo Paul E. , Choyke Peter L. , Allen Clint , Kobayashi Hisataka
Published: April 2023

Supplementary Video 1. NIR-PIT effect for MC38-luc cells. Immediately after exposure to excitation light, cellular swelling, bleb formation, and rupture of vesicles representing necrotic cell death were observed.
Figure S3 from Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA
Authors: Kundu Kiran , Ghosh Susmita , Sarkar Rhitajit , Edri Avishay , Brusilovsky Michael , Gershoni-Yahalom Orly , Yossef Rami , Shemesh Avishai , Soria Jean-Charles , Lazar Vladimir , Joshua Ben-Zion , Campbell Kerry S. , Elkabets Moshe , Porgador Angel
Published: April 2023

Purity of autologous NK cells and inhibition in proliferation of tumor cells by 14-25-9.
Figure S2 from Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA
Authors: Kundu Kiran , Ghosh Susmita , Sarkar Rhitajit , Edri Avishay , Brusilovsky Michael , Gershoni-Yahalom Orly , Yossef Rami , Shemesh Avishai , Soria Jean-Charles , Lazar Vladimir , Joshua Ben-Zion , Campbell Kerry S. , Elkabets Moshe , Porgador Angel
Published: April 2023

Non specificity of 14-25-9 towards NK92-NKp44-3 cells and human primary NK cells.
Supplementary Table 2 from A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors
Authors: Rogers Laura M. , Wang Zhaoming , Mott Sarah L. , Dupuy Adam J. , Weiner George J.
Published: April 2023

All models filtered gCIS
Supplementary Data from A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells
Authors: Jung Keunok , Kim Jeong-Ah , Kim Ye-Jin , Lee Hyun Woo , Kim Chul-Ho , Haam Seokjin , Kim Yong-Sung
Published: April 2023

Supplementary Figures 1-7
Supplementary Figures from Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation
Authors: Rodrigues Mantuano Natália , Stanczak Michal A. , Oliveira Isadora de Araújo , Kirchhammer Nicole , Filardy Alessandra A. , Monaco Gianni , Santos Ronan Christian , Fonseca Agatha Carlos , Fontes Miguel , Bastos César de Souza , Dias Wagner B. , Zippelius Alfred , Todeschini Adriane R. , Läubli Heinz
Published: April 2023

Supplementary Figures 1-8
Figure S2 from T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity
Authors: Sharma Preeti , Harris Daniel T. , Stone Jennifer D. , Kranz David M.
Published: April 2023

Supplementary Figure S2: Flow cytometric analysis of T1 and RD1 TCR binding with MART-1/HLA-A2 or self-peptide TM74B/HLA-A2.
Figure S1 from T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity
Authors: Sharma Preeti , Harris Daniel T. , Stone Jennifer D. , Kranz David M.
Published: April 2023

Supplementary Figure S1: Fine specificity of T1 and RD1 TCR for binding with MART-1/HLA-A2.
Supplementary Tables from Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Authors: Danilova Ludmila , Ho Won Jin , Zhu Qingfeng , Vithayathil Teena , De Jesus-Acosta Ana , Azad Nilofer S. , Laheru Daniel A. , Fertig Elana J. , Anders Robert , Jaffee Elizabeth M. , Yarchoan Mark
Published: April 2023

Supplemental Tables
Figure S2 from IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
Authors: Shao Lulu , Hou Weizhou , Scharping Nicole E. , Vendetti Frank P. , Srivastava Rashmi , Roy Chandra Nath , Menk Ashley V. , Wang Yiyang , Chauvin Joe-Marc , Karukonda Pooja , Thorne Stephen H. , Hornung Veit , Zarour Hassane M. , Bakkenist Christopher J. , Delgoffe Greg M. , Sarkar Saumendra N.
Published: April 2023

Supplementary Figure S2
Figure S1 from IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell
Authors: Shao Lulu , Hou Weizhou , Scharping Nicole E. , Vendetti Frank P. , Srivastava Rashmi , Roy Chandra Nath , Menk Ashley V. , Wang Yiyang , Chauvin Joe-Marc , Karukonda Pooja , Thorne Stephen H. , Hornung Veit , Zarour Hassane M. , Bakkenist Christopher J. , Delgoffe Greg M. , Sarkar Saumendra N.
Published: April 2023

Supplementary Figure S1
Supplementary Figures 1-7 and Supplementary Tables 1 and 3 from MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma
Authors: Vignard Virginie , Labbé Maureen , Marec Nadège , André-Grégoire Gwennan , Jouand Nicolas , Fonteneau Jean-François , Labarrière Nathalie , Fradin Delphine
Published: April 2023

Supplementary Figures 1-7 and Supplementary Tables 1 and 3
Supplementary Table S2 from MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma
Authors: Martinez-Usatorre Amaia , Sempere Lorenzo F. , Carmona Santiago J. , Carretero-Iglesia Laura , Monnot Gwennaëlle , Speiser Daniel E. , Rufer Nathalie , Donda Alena , Zehn Dietmar , Jandus Camilla , Romero Pedro
Published: April 2023

Table S2. Statistical tests
Supplementary Figures and Table 1 from MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma
Authors: Martinez-Usatorre Amaia , Sempere Lorenzo F. , Carmona Santiago J. , Carretero-Iglesia Laura , Monnot Gwennaëlle , Speiser Daniel E. , Rufer Nathalie , Donda Alena , Zehn Dietmar , Jandus Camilla , Romero Pedro
Published: April 2023

Supplementary Figures and Table S1
Supplementary Table S1 from AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity
Authors: Terry Stéphane , Abdou Abderemane , Engelsen Agnete S.T. , Buart Stéphanie , Dessen Philippe , Corgnac Stéphanie , Collares Davi , Meurice Guillaume , Gausdal Gro , Baud Véronique , Saintigny Pierre , Lorens James B. , Thiery Jean-Paul , Mami-Chouaib Fathia , Chouaib Salem
Published: April 2023

Supplementary Table S1
Table S1: Somatic Mutations from Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair–Deficient Colorectal Cancer
Authors: Gurjao Carino , Liu David , Hofree Matan , AlDubayan Saud H. , Wakiro Isaac , Su Mei-Ju , Felt Kristen , Gjini Evisa , Brais Lauren K. , Rotem Asaf , Rosenthal Michael H. , Rozenblatt-Rosen Orit , Rodig Scott , Ng Kimmie , Van Allen Eliezer M. , Corsello Steven M. , Ogino Shuji , Regev Aviv , Nowak Jonathan A. , Giannakis Marios
Published: April 2023

Table S1
Supplement Tables and Figures from Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness
Authors: Goodman Aaron M. , Kato Shumei , Chattopadhyay Ranajoy , Okamura Ryosuke , Saunders Ila M. , Montesion Meagan , Frampton Garrett M. , Miller Vincent A. , Daniels Gregory A. , Kurzrock Razelle
Published: April 2023

Supplemental Tables 1-3 and Supplemental Figures 1-5
Supplementary Figures 1-4 from Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma
Authors: Stromnes Ingunn M. , Burrack Adam L. , Hulbert Ayaka , Bonson Patrick , Black Cheryl , Brockenbrough J. Scott , Raynor Jackson F. , Spartz Ellen J. , Pierce Robert H. , Greenberg Philip D. , Hingorani Sunil R.
Published: April 2023

Supplementary Figures 1-4
Figure S5 from Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Authors: Wijewarnasuriya Dinali , Bebernitz Christina , Lopez Andrea V. , Rafiq Sarwish , Brentjens Renier J.
Published: April 2023

(A) CAR T cells, day 0 before infusion, were characterized by flow cytometry. Data shown is mean +/- s.e.m. of three independent experiments. "ns" (not significant) by unpaired t test. (B) Representative flow cytometry plots of CAR T cell CD8+ and CD4+ ratios day 5 after infusion referenced in Figure 2D. (C) Representative flow cytometry plots of PD-1, LAG-3, and TIM-3 inhibitory receptor expression of CD8+ CAR T cells referenced in Figure 2E. (D) CAR T cells, day 5 after infusion, were characterized by flow cytometry. m1928ï�ºIL-12 CAR T cells, gated on CD8+ T cells, expressed higher levels of double positive inhibitory receptors, LAG-3;TIM-3 (*p=0.0397) and LAG-3;PD-1 (*p=0.001), and showed a trend toward higher levels of TIM-3;PD-1 (*p=0.0563). Data obtained is mean +/- s.e.m. of three independent experiments analyzed by unpaired t test.
Figure S4 from Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Authors: Wijewarnasuriya Dinali , Bebernitz Christina , Lopez Andrea V. , Rafiq Sarwish , Brentjens Renier J.
Published: April 2023

(A) CAR T cells, day 5 after infusion, were characterized by flow cytometry in terms of percentage and representative plots. m1928ï�ºIL-12 CAR T cells expressed higher levels of inhibitory receptors, PD-1 (*p=0.0015) and LAG-3 (*p=0.0491) and showed a trend toward higher levels of TIM-3 (*p=0.1715). Data obtained is mean +/- s.e.m. of three independent experiments analyzed by unpaired t test. (B) Representative flow cytometry plots of PD-1, LAG-3, and TIM-3 inhibitory receptor expression of CAR T cells referenced in Figure 2B.
Figure S3 from Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Authors: Wijewarnasuriya Dinali , Bebernitz Christina , Lopez Andrea V. , Rafiq Sarwish , Brentjens Renier J.
Published: April 2023

(A) CAR T cells were co-cultured with EL4mCD19 tumor cells and then assessed for cytotoxicity 4 hours later, using a luciferase killing assay. There was no difference in tumor lysis between CAR T cells and vex-GFP tagged CAR T cells (two-way ANOVA). Data shown is representative of two independent experiments. (B) Flow cytometry gating strategy to determine CD8+ and CD4+ ratio and PD-1, TIM-3, and LAG-3 inhibitory receptor expression.
Table S6 from A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy
Authors: Liu Si-Qi , Grantham Alyssa , Landry Casey , Granda Brian , Chopra Rajiv , Chakravarthy Srinivas , Deutsch Sabine , Vogel Markus , Russo Katie , Seiss Katherine , Tschantz William R. , Rejtar Tomas , Ruddy David A. , Hu Tiancen , Aardalen Kimberly , Wagner Joel P. , Dranoff Glenn , D'Alessio Joseph A.
Published: April 2023

Table S6
Table S5 from A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy
Authors: Liu Si-Qi , Grantham Alyssa , Landry Casey , Granda Brian , Chopra Rajiv , Chakravarthy Srinivas , Deutsch Sabine , Vogel Markus , Russo Katie , Seiss Katherine , Tschantz William R. , Rejtar Tomas , Ruddy David A. , Hu Tiancen , Aardalen Kimberly , Wagner Joel P. , Dranoff Glenn , D'Alessio Joseph A.
Published: April 2023

Table S5
Table S3 from A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy
Authors: Liu Si-Qi , Grantham Alyssa , Landry Casey , Granda Brian , Chopra Rajiv , Chakravarthy Srinivas , Deutsch Sabine , Vogel Markus , Russo Katie , Seiss Katherine , Tschantz William R. , Rejtar Tomas , Ruddy David A. , Hu Tiancen , Aardalen Kimberly , Wagner Joel P. , Dranoff Glenn , D'Alessio Joseph A.
Published: April 2023

Table S3
Supplementary Figures and Legends from A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy
Authors: Liu Si-Qi , Grantham Alyssa , Landry Casey , Granda Brian , Chopra Rajiv , Chakravarthy Srinivas , Deutsch Sabine , Vogel Markus , Russo Katie , Seiss Katherine , Tschantz William R. , Rejtar Tomas , Ruddy David A. , Hu Tiancen , Aardalen Kimberly , Wagner Joel P. , Dranoff Glenn , D'Alessio Joseph A.
Published: April 2023

Supplementary Figures and Legends
Table S2 from Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas
Authors: Bockmayr Michael , Klauschen Frederick , Maire Cecile L. , Rutkowski Stefan , Westphal Manfred , Lamszus Katrin , Schüller Ulrich , Mohme Malte
Published: April 2023

Gene expression signatures for immune and stromal cell populations.
Supplementary Fig 2 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Authors: Pavlick Anna , Blazquez Ana B. , Meseck Marcia , Lattanzi Michael , Ott Patrick A. , Marron Thomas U. , Holman Rose Marie , Mandeli John , Salazar Andres M. , McClain Christopher B. , Gimenez Gustavo , Balan Sreekumar , Gnjatic Sacha , Sabado Rachel Lubong , Bhardwaj Nina
Published: April 2023

Supplementary Fig 2
Table S2 from Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype
Authors: Paolini Léa , Adam Clément , Beauvillain Céline , Preisser Laurence , Blanchard Simon , Pignon Pascale , Seegers Valérie , Chevalier Louise-Marie , Campone Mario , Wernert Romuald , Verrielle Véronique , Raro Pedro , Ifrah Norbert , Lavoué Vincent , Descamps Philippe , Morel Alain , Catros Véronique , Tcherkez Guillaume , Lenaers Guy , Bocca Cinzia , Kouassi Nzoughet Judith , Procaccio Vincent , Delneste Yves , Jeannin Pascale
Published: April 2023

Table S2
Supplemental Figures and Table from Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable
Authors: Fabian Kellsye P. , Malamas Anthony S. , Padget Michelle R. , Solocinski Kristen , Wolfson Benjamin , Fujii Rika , Abdul Sater Houssein , Schlom Jeffrey , Hodge James W.
Published: April 2023

Supplemental figures s1-s3 and supplementary table 1
Figure S7 from Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer
Authors: Anderson Kristin G. , Voillet Valentin , Bates Breanna M. , Chiu Edison Y. , Burnett Madison G. , Garcia Nicolas M. , Oda Shannon K. , Morse Christopher B. , Stromnes Ingunn M. , Drescher Charles W. , Gottardo Raphael , Greenberg Philip D.
Published: April 2023

Figure S7: Serially transferred TCR1045 T cells infiltrate ID8VEGF tumors and non-tumor tissue but do not damage healthy Msln-expressing tissues.
Supplementary Tables 1-4 and Figures 1-4 from ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
Authors: Haines Brian B. , Denslow Agnieszka , Grzesik Peter , Lee Jennifer S. , Farkaly Terry , Hewett Jacqueline , Wambua Daniel , Kong Lingxin , Behera Prajna , Jacques Judith , Goshert Caitlin , Ball Michael , Colthart Allison , Finer Mitchel H. , Hayes Melissa W. , Feau Sonia , Kennedy Edward M. , Lerner Lorena , Quéva Christophe
Published: April 2023

Supplemental Tables and Figures
Figure S1 from Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer
Authors: Anderson Kristin G. , Voillet Valentin , Bates Breanna M. , Chiu Edison Y. , Burnett Madison G. , Garcia Nicolas M. , Oda Shannon K. , Morse Christopher B. , Stromnes Ingunn M. , Drescher Charles W. , Gottardo Raphael , Greenberg Philip D.
Published: April 2023

Figure S1: MSLN-specific engineered CD8 T cells induce cell death in HGSOC cell lines.
Supplementary Data 1 and 2 from Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti–PD-1 Therapy
Authors: Bortone Dante S. , Woodcock Mark G. , Parker Joel S. , Vincent Benjamin G.
Published: April 2023

Supplementary Data 1 - tab 1 These supplementary data for Fig. 4 show the expanded statistical results of univariable generalized linear model regressions performed on TCR diversity metrics and features commonly associated with diversity. BH_pValue is the result of a Benjamini-Hochberg FDR correction on the pValue column. Significance was calculated by -log10(BH_pValue). Supplementary Data 2 - tab 2 These supplementary data for Fig 5 show the expanded statistical results of univariable CoxPH regressions on diversity metrics and TCGA overall survival. BH_pValue is the result of a Benjamini-Hochberg FDR correction on the pValue column. Significance was calculated by -log10(BH_pValue).
Supplementary Data from Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer
Authors: Umer Brittany A. , Noyce Ryan S. , Franczak Brian C. , Shenouda Mira M. , Kelly Rees G. , Favis Nicole A. , Desaulniers Megan , Baldwin Troy A. , Hitt Mary M. , Evans David H.
Published: April 2023

Supplemental tables 1-2 and supplemental figures 1-7
Figure S1-S8 from CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function
Authors: Sahillioglu Ali Can , Toebes Mireille , Apriamashvili Georgi , Gomez Raquel , Schumacher Ton N.
Published: April 2023

Supplementary Figure S1-S8
Supplementary Data from Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform
Authors: Gejman Ron S. , Jones Heather F. , Klatt Martin G. , Chang Aaron Y. , Oh Claire Y. , Chandran Smita S. , Korontsvit Tatiana , Zakahleva Viktoriya , Dao Tao , Klebanoff Christopher A. , Scheinberg David A.
Published: April 2023

Supplementary Tables and Figures
Supplementary Table S1 from Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
Authors: Lauret Marie Joseph Elodie , Laheurte Caroline , Jary Marine , Boullerot Laura , Asgarov Kamal , Gravelin Eléonore , Bouard Adeline , Rangan Laurie , Dosset Magalie , Borg Christophe , Adotévi Olivier
Published: April 2023

Patient's main clinical characteristics.
Supplementary Material and Methods from Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
Authors: Lauret Marie Joseph Elodie , Laheurte Caroline , Jary Marine , Boullerot Laura , Asgarov Kamal , Gravelin Eléonore , Bouard Adeline , Rangan Laurie , Dosset Magalie , Borg Christophe , Adotévi Olivier
Published: April 2023

Flow cytometry antibody, qPCR and Quantibrite protocol.
Supplementary Figure S3 from Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer
Authors: Lauret Marie Joseph Elodie , Laheurte Caroline , Jary Marine , Boullerot Laura , Asgarov Kamal , Gravelin Eléonore , Bouard Adeline , Rangan Laurie , Dosset Magalie , Borg Christophe , Adotévi Olivier
Published: April 2023

ANGPT2 inhibitory effect against TERT-specific T cell responses.
Figure S4 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
Authors: Conti Laura , Bolli Elisabetta , Di Lorenzo Antonino , Franceschi Valentina , Macchi Francesca , Riccardo Federica , Ruiu Roberto , Russo Luca , Quaglino Elena , Donofrio Gaetano , Cavallo Federica
Published: April 2023

Figure S4
Figure S1 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
Authors: Conti Laura , Bolli Elisabetta , Di Lorenzo Antonino , Franceschi Valentina , Macchi Francesca , Riccardo Federica , Ruiu Roberto , Russo Luca , Quaglino Elena , Donofrio Gaetano , Cavallo Federica
Published: April 2023

Figure S1
Figure S3 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
Authors: Capietto Aude-Hélène , Lee Seunghyun , Clever David , Eul Emily , Ellis Haley , Ma Cynthia X. , Faccio Roberta
Published: April 2023

Bone marrow CD11b+/Ly6Cint/Ly6Gint cells lack immune suppressive capacities
Figure S1 from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets
Authors: Capietto Aude-Hélène , Lee Seunghyun , Clever David , Eul Emily , Ellis Haley , Ma Cynthia X. , Faccio Roberta
Published: April 2023

Anti-Gr1 Ab treatment reduces soft tissue tumor growth
Supplementary Tables from Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s
Authors: Daugan Marie V. , Revel Margot , Russick Jules , Dragon-Durey Marie-Agnès , Gaboriaud Christine , Robe-Rybkine Tania , Poillerat Victoria , Grunenwald Anne , Lacroix Guillaume , Bougouin Antoine , Meylan Maxime , Verkarre Virginie , Oudard Stephane M. , Mejean Arnaud , Vano Yann A. , Perkins Geraldine , Validire Pierre , Cathelineau Xavier , Sanchez-Salas Rafael , Damotte Diane , Fremeaux-Bacchi Veronique , Cremer Isabelle , Sautès-Fridman Catherine , Fridman Wolf H. , Roumenina Lubka T.
Published: April 2023

Supplementary Tables 1-3
Supplementary Figures from Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s
Authors: Daugan Marie V. , Revel Margot , Russick Jules , Dragon-Durey Marie-Agnès , Gaboriaud Christine , Robe-Rybkine Tania , Poillerat Victoria , Grunenwald Anne , Lacroix Guillaume , Bougouin Antoine , Meylan Maxime , Verkarre Virginie , Oudard Stephane M. , Mejean Arnaud , Vano Yann A. , Perkins Geraldine , Validire Pierre , Cathelineau Xavier , Sanchez-Salas Rafael , Damotte Diane , Fremeaux-Bacchi Veronique , Cremer Isabelle , Sautès-Fridman Catherine , Fridman Wolf H. , Roumenina Lubka T.
Published: April 2023

Supplementary Figures 1-15
Table S5 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
Authors: Kikuchi Yasuhiro , Tokita Serina , Hirama Tomomi , Kochin Vitaly , Nakatsugawa Munehide , Shinkawa Tomoyo , Hirohashi Yoshihiko , Tsukahara Tomohide , Hata Fumitake , Takemasa Ichiro , Sato Noriyuki , Kanaseki Takayuki , Torigoe Toshihiko
Published: April 2023

Table S5
Table S2 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
Authors: Kikuchi Yasuhiro , Tokita Serina , Hirama Tomomi , Kochin Vitaly , Nakatsugawa Munehide , Shinkawa Tomoyo , Hirohashi Yoshihiko , Tsukahara Tomohide , Hata Fumitake , Takemasa Ichiro , Sato Noriyuki , Kanaseki Takayuki , Torigoe Toshihiko
Published: April 2023

Table S2
Table S1 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
Authors: Kikuchi Yasuhiro , Tokita Serina , Hirama Tomomi , Kochin Vitaly , Nakatsugawa Munehide , Shinkawa Tomoyo , Hirohashi Yoshihiko , Tsukahara Tomohide , Hata Fumitake , Takemasa Ichiro , Sato Noriyuki , Kanaseki Takayuki , Torigoe Toshihiko
Published: April 2023

Table S1
Figure S1-S7 from CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA PVT1
Authors: Kikuchi Yasuhiro , Tokita Serina , Hirama Tomomi , Kochin Vitaly , Nakatsugawa Munehide , Shinkawa Tomoyo , Hirohashi Yoshihiko , Tsukahara Tomohide , Hata Fumitake , Takemasa Ichiro , Sato Noriyuki , Kanaseki Takayuki , Torigoe Toshihiko
Published: April 2023

Figures S1-S7
Supplementary Figure from Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
Authors: Dinavahi Saketh S. , Chen Yu-Chi , Punnath Kishore , Berg Arthur , Herlyn Meenhard , Foroutan Momeneh , Huntington Nicholas D. , Robertson Gavin P.
Published: April 2023

Supplementary Figure from Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
Supplementary Data from Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation
Authors: Milling Lauren E. , Garafola Daniel , Agarwal Yash , Wu Shengwei , Thomas Ayush , Donahue Nathan , Adams Josetta , Thai Nikki , Suh Heikyung , Irvine Darrell J.
Published: April 2023

Supplementary Data from Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation
Supplementary Data from Arginase 1–Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti–PD-1 Checkpoint Blockade
Authors: Aaboe Jørgensen Mia , Ugel Stefano , Linder Hübbe Mie , Carretta Marco , Perez-Penco Maria , Weis-Banke Stine Emilie , Martinenaite Evelina , Kopp Katharina , Chapellier Marion , Adamo Annalisa , De Sanctis Francesco , Frusteri Cristina , Iezzi Manuela , Zocca Mai-Britt , Hargbøll Madsen Daniel , Wakatsuki Pedersen Ayako , Bronte Vincenzo , Andersen Mads Hald
Published: April 2023

Collected supplementary data file with figures and figure legends.
Supplementary Figure from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Authors: Samson Adel , West Emma J. , Carmichael Jonathan , Scott Karen J. , Turnbull Samantha , Kuszlewicz Bethany , Dave Rajiv V. , Peckham-Cooper Adam , Tidswell Emma , Kingston Jennifer , Johnpulle Michelle , da Silva Barbara , Jennings Victoria A. , Bendjama Kaidre , Stojkowitz Nicolas , Lusky Monika , Prasad K.R. , Toogood Giles J. , Auer Rebecca , Bell John , Twelves Chris J. , Harrington Kevin J. , Vile Richard G. , Pandha Hardev , Errington-Mais Fiona , Ralph Christy , Newton Darren J. , Anthoney Alan , Melcher Alan A. , Collinson Fiona
Published: April 2023

Supplementary Figure from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Supplementary Tables and Figures from Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma
Authors: Chiaro Jacopo , Kasanen Henna H.E. , Whalley Thomas , Capasso Cristian , Grönholm Mikaela , Feola Sara , Peltonen Karita , Hamdan Firas , Hernberg Micaela , Mäkelä Siru , Karhapää Hanna , Brown Paul E. , Martins Beatriz , Fusciello Manlio , Ylösmäki Erkko O. , Greco Dario , Kreutzman Anna S. , Mustjoki Satu , Szomolay Barbara , Cerullo Vincenzo
Published: April 2023

Supplementary Tables 1-3 and Figures 1-6
Supplementary Data from An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity
Authors: He Xuedan , Zhou Shiqi , Quinn Breandan , Jahagirdar Dushyant , Ortega Joaquin , Long Mark D. , Abrams Scott I. , Lovell Jonathan F.
Published: April 2023

Supplementary Data from An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity
Supplementary Data from Circulating Tregs Accumulate in Omental Tumors and Acquire Adipose-Resident Features
Authors: Liu Mingyong , Starenki Dmytro , Scharer Christopher D. , Silva-Sanchez Aaron , Molina Patrick A. , Pollock Jennifer S. , Cooper Sara J. , Arend Rebecca C. , Rosenberg Alexander F. , Randall Troy D. , Meza-Perez Selene
Published: April 2023

Supplementary Data from Circulating Tregs Accumulate in Omental Tumors and Acquire Adipose-Resident Features
Supplemental Figures and Legends from Metabolic Screening of Cytotoxic T-cell Effector Function Reveals the Role of CRAC Channels in Regulating Lethal Hit Delivery
Authors: Slaats Jeroen , Dieteren Cindy E. , Wagena Esther , Wolf Louis , Raaijmakers Tonke K. , van der Laak Jeroen A. , Figdor Carl G. , Weigelin Bettina , Friedl Peter
Published: April 2023

Supplemental Figures and Legends for Supplemental Figures S1-S8, and Movie Legends for Movies 1-7
Movie 6 from Metabolic Screening of Cytotoxic T-cell Effector Function Reveals the Role of CRAC Channels in Regulating Lethal Hit Delivery
Authors: Slaats Jeroen , Dieteren Cindy E. , Wagena Esther , Wolf Louis , Raaijmakers Tonke K. , van der Laak Jeroen A. , Figdor Carl G. , Weigelin Bettina , Friedl Peter
Published: April 2023

Human CTL engagement with an αCD3-coated surface in the absence (DMSO) or presence of BTP2. Morgenstemning LUT, Fura-2 340/380 ratio. Time stamp, min:sec (0 min denoting the time-point of contact initiation). Scale bar, 10 µm.
Movie 5 from Metabolic Screening of Cytotoxic T-cell Effector Function Reveals the Role of CRAC Channels in Regulating Lethal Hit Delivery
Authors: Slaats Jeroen , Dieteren Cindy E. , Wagena Esther , Wolf Louis , Raaijmakers Tonke K. , van der Laak Jeroen A. , Figdor Carl G. , Weigelin Bettina , Friedl Peter
Published: April 2023

OT-I CTL conjugation with MEC1/OVA cells in the absence (DMSO) or presence of BTP2. Time stamp, min:sec. Fire LUT, Fura-2 340/380-ratio. Scale bar, 10 µm.
Supplementary Tables from Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients
Authors: Lulu Amanda M. , Cummings Kara L. , Jeffery Erin D. , Myers Paisley T. , Underwood Dennis , Lacy Rachel M. , Chianese-Bullock Kimberly A. , Slingluff Craig L. , Modesitt Susan C. , Engelhard Victor H.
Published: April 2023

Supplementary Tables
Supplementary Figures from Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients
Authors: Lulu Amanda M. , Cummings Kara L. , Jeffery Erin D. , Myers Paisley T. , Underwood Dennis , Lacy Rachel M. , Chianese-Bullock Kimberly A. , Slingluff Craig L. , Modesitt Susan C. , Engelhard Victor H.
Published: April 2023

Supplementary Figures
figure S2 from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer
Authors: Ji Niannian , Mukherjee Neelam , Shu Zhen-Ju , Reyes Ryan M. , Meeks Joshua J. , McConkey David J. , Gelfond Jonathan A. , Curiel Tyler J. , Svatek Robert S.
Published: April 2023

Figure.S2 shows that protective immunity against MB49 tumor in mice can not prevent the growth of B16 melanoma tumor.
Supplementary Data from T Cell–Mediated Targeted Delivery of Anti–PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site
Authors: Petit Pierre-Florent , Bombart Raphaële , Desimpel Pierre-Hubert , Naulaerts Stefan , Thouvenel Laurie , Collet Jean-François , Van den Eynde Benoit J. , Zhu Jingjing
Published: April 2023

Supplementary Data from T Cell–Mediated Targeted Delivery of Anti–PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site
Figure S7 from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer
Authors: Ji Niannian , Mukherjee Neelam , Shu Zhen-Ju , Reyes Ryan M. , Meeks Joshua J. , McConkey David J. , Gelfond Jonathan A. , Curiel Tyler J. , Svatek Robert S.
Published: April 2023

Figure S7 - Figure.S7 shows combination of rapamycin and BCG increase absolute number of human effector memory γδ T cells expanded in vitro and reduce the growth of patient-derived xenograft bladder cancer cells in vivo.
Supplementary Figure from Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies
Authors: Song Li , Ouyang Zhangyi , Cohen David , Cao Yang , Altreuter Jennifer , Bai Gali , Hu Xihao , Livak Kenneth J. , Li Heng , Tang Ming , Li Bo , Liu X. Shirley
Published: April 2023

Supplementary Figure from Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies
Movie S1 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
Authors: Kantari-Mimoun Chahrazade , Barrin Sarah , Vimeux Lene , Haghiri Sandrine , Gervais Claire , Joaquina Sandy , Mittelstaet Joerg , Mockel-Tenbrinck Nadine , Kinkhabwala Ali , Damotte Diane , Lupo Audrey , Sibony Mathilde , Alifano Marco , Dondi Elisabetta , Bercovici Nadège , Trautmann Alain , Kaiser Andrew D. , Donnadieu Emmanuel
Published: April 2023

Ca2+ responses of Fura-2-loaded CD20 CAR T cells during their interaction with Raji B cells.
Legends for supplementary figures and Videos from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
Authors: Kantari-Mimoun Chahrazade , Barrin Sarah , Vimeux Lene , Haghiri Sandrine , Gervais Claire , Joaquina Sandy , Mittelstaet Joerg , Mockel-Tenbrinck Nadine , Kinkhabwala Ali , Damotte Diane , Lupo Audrey , Sibony Mathilde , Alifano Marco , Dondi Elisabetta , Bercovici Nadège , Trautmann Alain , Kaiser Andrew D. , Donnadieu Emmanuel
Published: April 2023

Legends for supplementary Figures and Videos
Figure S1 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
Authors: Kantari-Mimoun Chahrazade , Barrin Sarah , Vimeux Lene , Haghiri Sandrine , Gervais Claire , Joaquina Sandy , Mittelstaet Joerg , Mockel-Tenbrinck Nadine , Kinkhabwala Ali , Damotte Diane , Lupo Audrey , Sibony Mathilde , Alifano Marco , Dondi Elisabetta , Bercovici Nadège , Trautmann Alain , Kaiser Andrew D. , Donnadieu Emmanuel
Published: April 2023

CAR T cell responsiveness is dependent on the spatial orientation of carcinoma cells
Supplementary Table from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
Authors: Gil Del Alcazar Carlos R. , Trinh Anne , Alečković Maša , Rojas Jimenez Ernesto , Harper Nicholas W. , Oliphant Michael U.J. , Xie Shanshan , Krop Ethan D. , Lulseged Bethlehem , Murphy Katherine C. , Keenan Tanya E. , Van Allen Eliezer M. , Tolaney Sara M. , Freeman Gordon J. , Dillon Deborah A. , Muthuswamy Senthil K. , Polyak Kornelia
Published: April 2023

Supplementary Table from Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
Supplementary Video Legends and Figures from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
Authors: Wellinger Lisa C. , Hogg Simon J. , Newman Dane M. , Friess Thomas , Geiss Daniela , Michie Jessica , Ramsbottom Kelly M. , Bacac Marina , Fauti Tanja , Marbach Daniel , Jarassier Laura , Thienger Phillip , Paehler Axel , Cluse Leonie A. , Kearney Conor J. , Vervoort Stephin J. , Trapani Joseph A. , Oliaro Jane , Shortt Jake , Ruefli-Brasse Astrid , Rohle Daniel , Johnstone Ricky W.
Published: April 2023

Supplementary Video Legends and Supplementary Figures 1-10
Supplementary Figure from PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling
Authors: Wanderley Carlos Wagner S. , Maganin Alexandre G.M. , Adjafre Beatriz , Mendes Atlante S. , Silva Conceição Elidianne Anibal , Quadros Andreza Urba , Luiz João Paulo Mesquita , Silva Camila Meirelles S. , Silva Nicole R. , Oliveira Francisco Fabio Bezerra , Gomes Francisco Isaac F. , Restrepo Jeferson Leandro J. , Speck-Hernandez Cesar A. , Turaça Fernanda , Silva Gabriel Victor Lucena , Pigatto Glauce R. , Nakaya Helder I. , Mota Jose Mauricio , Barroso-Sousa Romualdo , Alves-Filho José C. , Cunha Thiago M. , Cunha Fernando Q.
Published: April 2023

Supplementary Figure from PD-1/PD-L1 Inhibition Enhances Chemotherapy-Induced Neuropathic Pain by Suppressing Neuroimmune Antinociceptive Signaling
Supplementary Figure from cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1
Authors: Ferris Stephen T. , Ohara Ray A. , Ou Feiya , Wu Renee , Huang Xiao , Kim Sunkyung , Chen Jing , Liu Tian-Tian , Schreiber Robert D. , Murphy Theresa L. , Murphy Kenneth M.
Published: April 2023

Supplementary Figure from cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1
Supplementary Figure from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
Authors: Kim Sanghyun P. , Vale Nolan R. , Zacharakis Nikolaos , Krishna Sri , Yu Zhiya , Gasmi Billel , Gartner Jared J. , Sindiri Sivasish , Malekzadeh Parisa , Deniger Drew C. , Lowery Frank J. , Parkhurst Maria R. , Ngo Lien T. , Ray Satyajit , Li Yong F. , Hill Victoria , Florentin Maria , Masi Robert V. , Paria Biman C. , Levin Noam , Bera Alakesh , Hedges Elizabeth A. , Choi Agnes , Chatani Praveen D. , Parikh Anup Y. , Levi Shoshana , Seitter Samantha , Lu Yong-Chen , Zheng Zhili , Prickett Todd D. , Jia Li , Hernandez Jonathan M. , Hoang Chuong D. , Robbins Paul F. , Goff Stephanie L. , Sherry Richard M. , Yang James C. , Rosenberg Steven A.
Published: April 2023

Supplementary Figure from Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors